Nivolumab +/- Relatlimab Prior to Chemoradiation With II/III Gastro/Esophageal Cancer

NCT03044613 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
Esophageal Cancer
GastroEsophageal Cancer

Interventions

DRUG: Nivolumab
DRUG: Relatlimab
DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: Radiation

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]